Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

January

26

electroCore, Inc. Announces Exclusive Distribution Agreement with RSK Medical Inc. in Canada

RSK Medical will serve as exclusive distributor of the gammaCore Sapphire™ in Canada, supplying therapy...

21

Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the...

21

electroCore, Inc. Announces Scottish Health Technology Group Recommendation For Use of gammaCore™ in NHS Scotland Cluster Headache Patients

Publication based on guidance produced in 2019 by the U.K. National Institute for Health and...

19

electroCore, Inc. Announces the Establishment of a Unique Level II HCPCS Code for “Non-Invasive Vagus Nerve Stimulator”

Decision covering gammaCore Sapphire™ D will go into effect April 1, 2021 ROCKAWAY, N.J., Jan. 19,...

12

ATEC Announces Preliminary 2020 Revenue Results

Full-year 2020 U.S. revenue growth exceeded 30%; fourth quarter 2020 U.S. revenue grew over 38%...

11

electroCore Provides Business Update and Select Financial Guidance

Full year 2020 revenue expected at the upper end of previously announced guidance range...

10

Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

Record Testing Revenue, Adopters and AVISE CTD® Volumes SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...

21

electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for gammaCore Sapphire™ in Eastern Europe

Agreement covers Lithuania, Latvia, Belarus, Kazakhstan and Ukraine ROCKAWAY, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic...

17

ATEC Continues To Advance Clinical Prowess With Renewed Agreement To Acquire EOS Imaging

Improves clinical performance in spine by adding unprecedented information to the AlphaInformatiX Platform Accelerates...

8

electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study

All study endpoints showed benefit from non-invasive vagus nerve stimulation, with many endpoints showing...

1

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders

Randomized controlled study run by Dr. Douglas Bremner at Emory University in collaboration with the Georgia Institute of Technology and...

16

Exagen and GSK Partner for Fourth Straight Year

Continued collaboration drives greater awareness of challenges facing lupus diagnosis and management SAN DIEGO, Nov....

Recent developments

News

January

26

electroCore, Inc. Announces Exclusive Distribution Agreement with RSK Medical Inc. in Canada

January

21

Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

January

21

electroCore, Inc. Announces Scottish Health Technology Group Recommendation For Use of gammaCore™ in NHS Scotland Cluster Headache Patients

January

19

electroCore, Inc. Announces the Establishment of a Unique Level II HCPCS Code for “Non-Invasive Vagus Nerve Stimulator”

January

12

ATEC Announces Preliminary 2020 Revenue Results

January

11

electroCore Provides Business Update and Select Financial Guidance

January

10

Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

December

21

electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for gammaCore Sapphire™ in Eastern Europe

December

17

ATEC Continues To Advance Clinical Prowess With Renewed Agreement To Acquire EOS Imaging

December

8

electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study

December

1

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders

November

16

Exagen and GSK Partner for Fourth Straight Year